Skip to content
PoliticalRepoPoliticalRepo

France · Amendment · Amendement

AS616

Amendement AS616 — ART. 34

rejectedFrance· National Assembly· FR

Introduced

11 October 2019

Last action

16 October 2019 · Rejeté

Status

Rejeté

Sponsors

Guillaume Larrivé, Maxime Minot, Bernard Perrut, Bérengère Poletti, Arnaud Viala, Jean-Claude Bouchet, Julien Dive, Josiane Corneloup, Jean-Carles Grelier, Marc Le Fur, Alain Ramadier, Robin Reda, Fabrice Brun, Éric Straumann

Subjects

Discovery layer

Source updated

16 October 2019

Official sourceShare

Summary

Après l’alinéa 36, insérer l’alinéa suivant : « Les entreprises pharmaceutiques sont exemptées de sanctions financières pour les manquements mentionnés à l’article L. 5423‑9, lorsque ces manquements concernent des médicaments dérivés du plasma ».

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 11 October 2019

    Dépôt

    Source: dateDepot

  2. 16 October 2019

    Publication

    Source: datePublication

  3. 16 October 2019

    Rejeté

    Source: dateSort

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Reading translation

Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.